Lexicon Pharmaceuticals (LXRX) Invested Capital (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Invested Capital of $4.6 million for Q4 2025, down 89.07% quarter-over-quarter from $42.1 million in Q1 2025.
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) Invested Capital (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Invested Capital for 13 consecutive years, with $4.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Invested Capital changed N/A year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (down 89.07% YoY), while the FY2025 annual figure was $4.6 million, changed N/A from the prior year.
- Invested Capital declined to $4.6 million in Q4 2025 per LXRX's latest filing, from $42.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $42.1 million in Q1 2025 and bottomed at $4.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Lexicon Pharmaceuticals | 978.15 Mn | 787.54 Mn | 653,000.00 | 225.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 225.96 Mn |
| Mar 31, 2026 | 499.68 Mn |
| Dec 31, 2025 | 161.54 Mn |
| Sep 30, 2025 | 176.67 Mn |
| Jun 30, 2025 | 185.55 Mn |
| Mar 31, 2025 | 223.73 Mn |
| Dec 31, 2024 | 246.25 Mn |
| Sep 30, 2024 | 278.41 Mn |
| Jun 30, 2024 | 339.48 Mn |
| Mar 31, 2024 | 549.90 Mn |
| Dec 31, 2023 | 192.62 Mn |
| Sep 30, 2023 | 238.81 Mn |
| Jun 30, 2023 | 285.16 Mn |
| Mar 31, 2023 | 136.89 Mn |
| Dec 31, 2022 | 348.58 Mn |
| Sep 30, 2022 | 167.82 Mn |
| Jun 30, 2022 | 94.46 Mn |
| Mar 31, 2022 | 116.20 Mn |
| Dec 31, 2021 | 300.00 Mn |
| Sep 30, 2021 | 148.30 Mn |